ClearPoint Neuro (CLPT)
(Real Time Quote from BATS)
$6.12 USD
-0.28 (-4.38%)
Updated May 17, 2024 02:56 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CLPT 6.12 -0.28(-4.38%)
Will CLPT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CLPT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLPT
Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should Know
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
CLPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
Other News for CLPT
ClearPoint Neuro Stockholders Approve Key Proposals and Directors
Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
ClearPoint Neuro: A Strong Buy on Robust Revenue Growth and Strategic Advancements
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
ClearPoint Neuro Reports First Quarter 2024 Results